Frequency Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Korro Bio

12/05/2023 21:49

* Frequency Therapeutics Inc  FREQ.OQ  reported a quarterly
adjusted loss of 55 cents​​ per share for the quarter ended in
March. The mean expectation of four analysts for the quarter was
for a loss of 42 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Frequency Therapeutics Inc's reported EPS for the quarter
was a
loss of 55 cents​.
    * The mean earnings estimate of analysts had risen by
about 29.5%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Frequency Therapeutics Inc shares had fallen by 25.8% this
quarter and lost 90.3% so far this year.
    * The company reported a quarterly loss of $19.54 million.
    * Wall Street's median 12-month price target for Frequency
Therapeutics Inc is $4.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 3
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
12 at 08:49 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.42          -0.55          Missed
 Dec. 31 2022      -0.63          -0.49          Beat
 Sep. 30 2022      -0.57          -0.55          Beat
 Jun. 30 2022      -0.67          -0.61          Beat